Great West Life Assurance Co. Can bought a new position in the shares of Ambev SA (NYSE: ABEV – Get an estimate) in the third quarter, according to the latest information released to the Securities and Exchange Commission (SEC). The firm purchased 7,410,978 shares of the company’s stock, valued at approximately $21,152,000.
Several other institutional investors also recently bought and sold shares of ABEV. YorkBridge Wealth Partners LLC lifted its position in Ambev by 3.8% during the third quarter. YorkBridge Wealth Partners LLC now owns 101,551 shares of the company’s stock valued at $287,000 after buying an additional 3,684 shares in the last quarter. Park Avenue Securities LLC lifted its position in Ambev by 10.0% during the second quarter. Park Avenue Securities LLC now owns 41,082 shares of the company’s stock worth $103,000 after purchasing an additional 3,727 shares in the last quarter. Scotia Capital Inc. raised its position in Ambev by 0.3% during the second quarter. Scotia Capital Inc now owns 1,270,909 shares of the company’s stock valued at $3,190,000 after buying an additional 3,727 shares in the last quarter. Jarislowsky Fraser Ltd raised its stake in Ambev by 11.6% during the second quarter. Jarislowsky Fraser Ltd now owns 38,153 shares of the company’s stock valued at $95,000 after acquiring an additional 3,960 shares during the last quarter. Finally, Moors & Cabot Inc. increased its stake in Ambev by 7.2% during the second quarter. Moors & Cabot Inc. now owns 61,500 shares of the company’s stock valued at $154,000 after acquiring an additional 4,150 shares during the last quarter. 8.75% of the shares belong to institutional investors and hedge funds.
Ambev Price Performance
ABEV in stock opened at $2.72 on Wednesday. Ambev SA has a 52 week low of $2.42 and a 52 week high of $3.32. The company has a quick ratio of 0.83, a current ratio of 1.19, and a debt-to-equity ratio of 0.02. The company has a fifty day moving average of $2.85 and a two hundred day moving average of $2.86. The stock has a market cap of $42.81 billion, a price-to-earnings ratio of 17.00, a price-to-earnings-growth ratio of 1.75 and a beta of 1.04.
Ambev (NYSE: ABEV – Get an estimate) last released its quarterly earnings data on Thursday, October 27th. The company reported $0.04 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01. Ambevi’s return on equity was 15.69% and its net margin was 16.58%. The company had revenue of $3.93 billion during the quarter, compared to analysts’ expectations of $3.87 billion. research analysts anticipate that Ambev SA will post 0.15 earnings per share for the current year.
Ambev’s dividend announcement
The company also recently disclosed an annual dividend, which was paid on Monday, January 9th. Shareholders of record on Wednesday, December 21st were paid a $0.1457 dividend. The ex-dividend date was Tuesday, December 20th. This makes the dividend yield 3.8%. Ambev’s payout ratio is currently 75.00%.
Wall Street analysts predict economic growth
A number of equities research analysts have issued reports on the company. UBS Group raised Ambev from a “sell” rating to a “buy” rating in a research note on Thursday, January 12th. TheStreet raised Ambev from a “c+” rating to a “b” rating in a research note on Friday, December 9th. Finally StockNews.com expected Ambev in a research report on Thursday, January 12th. They assigned a “buy” rating to the company. Four investment analysts have rated the stock with a buy rating, with an average rating of “Buy”, according to MarketBeat .
Ambev SA produces, distributes and sells beer, draft beer, carbonated soft drinks, other non-alcoholic drinks, malt and foodstuffs through its subsidiaries. The company operates through four segments: Brazil; Central America and the Caribbean; South Latin America; and Canada. It offers beer mainly Skol, Brahma, Antarctica, Brahva, Brahva Gold, Extra, Bud Light, Beck, Leffe and Hoegaarden, Bucanero, Cristali, Mayabe, Cacique, Presidente, Brahma Light, Presidente Light, Presidente Golden Light, Bohemia, The One , Corona, Modelo Especial, Stella Artois and Budweiser, Quilmes Clásica, Paceña, Taquiña, Huari, Becker, Cusqueña, Michelob Ultra, Busch, Pilsen, Ouro Fino, Banks, Deputy, Patricia, Labatt Blue, Alexander Keith’s and Kokanee brands.
This breaking news alert was created using MarketBeat’s narrative research technology and financial data to provide readers with the fastest and most accurate reporting. MarketBeat editorial staff reviewed this story prior to publication. Please direct any questions or comments about this story to firstname.lastname@example.org.
You’ll want to hear this before you consider Ambevi.
MarketBeat tracks Wall Street’s top-rated and best-performing research analysts daily and the stocks they recommend to their clients. MarketBeat has identified five shares that top analysts are quietly whispering to their clients to buy now before the broader market kicks in… and Ambev was not on the list.
While Ambevi currently has a “Buy” rating among analysts, the top rated analysts believe these five stocks are better buys.